IDIM 12530
INSTITUTO DE INVESTIGACIONES MEDICAS
Unidad Ejecutora - UE
artículos
Título:
Nonalcoholic fatty liver disease: Biomarkers support decisions around pharmacological intervention
Autor/es:
PIROLA, CARLOS J.; SOOKOIAN, SILVIA
Revista:
HEPATOLOGY (BALTIMORE, MD.)
Editorial:
JOHN WILEY & SONS INC
Referencias:
Lugar: Baltimore; Año: 2017 vol. 65 p. 1417 - 1419
ISSN:
0270-9139
Resumen:
NAFLDpathogenesis involves highly interconnected mechanisms of which the moleculartaxonomy is more complex than the mere accumulation of fat in the liver. Infact, as in many Metabolic Syndrome components, the pathways involved reflect alow to moderate degree of inflammation as simply shown by an increasedleukocyte count. Therefore, it is reasonable to assume that NAFLD requires notonly of precision diagnosis but precision treatment.
